Table 3. Cardiovascular disease risk factors in women with prior preeclampsia compared to control subjects.
Characteristic | Prior preeclampsia (n = 49) | Controls (n = 22) | P value |
---|---|---|---|
Systolic BP, mm Hg | 114.6 ± 10.9 | 102.3 ± 7.5 | < .001 |
Diastolic BP, mm Hg | 67.6 ± 7.5 | 60.9 ± 3.6 | < .001 |
FMD (% change) | 4.5 [2−6.7] | 8.8 [4.5−9.1] | < .05 |
NMD (% change) | 19.4 [16.4−23] | 22.5 [16.8−26.3] | .2 |
Total cholesterol, mg/dL | 166.0 ± 30.0 | 169.6 ± 41.4 | .7 |
HDL cholesterol, mg/dL | 46.0 ± 10.7 | 51.3 ± 9.3 | < .05 |
Triglycerides, mg/dL | 69 [52−100] | 55 [45−80] | .2 |
LDL cholesterol, mg/dL | 104 [84−123] | 103 [83−114] | .6 |
LDL peak buoyancy (Rf) | 0.276 ± 0.022 | 0.289 ± 0.016 | .02 |
Hepatic lipase activity, nmol/mL/min | 308 [224−393] | 243 [217−286] | .04 |
Data are mean ± SD or median [25th—75th percentile].
BP, blood pressure; FMD, flow-mediated dilatation; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NMD, nitroglycerine-mediated dilatation; RF, relative flotation rate.